Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Explore clinical trials studying Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Study availability and eligibility vary by location and protocol.

607 public trials 71 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trial results

Active, not recruiting

Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP)

NCT04160546

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, Chronic Phase, +12 more
Locations
  • Institut Català D'Oncologia L'Hospitalet (ICO) L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital General Universitario Gregorio Marañón Madrid, Spain
  • Hospital Ramón y Cajal Madrid, Spain
  • Hospital Universitario y Politécnico La Fe Valencia, Spain
View all 13 locations
View Trial Details
Completed

Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator

NCT01742299

Conditions
Bone Marrow Diseases, Chronic Disease, Digestive System Diseases, +18 more
Locations
  • University of California LA Los Angeles, California, United States
  • Northwestern University Chicago, Illinois, United States
  • Sidney Kimmel CCC At JH Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 29 locations
View Trial Details
Completed

Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs

NCT03106779

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • University of Chicago Hospital Chicago, Illinois, United States
  • Indiana Blood and Marrow Institute Beech Grove, Indiana, United States
  • Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Center Boston, Massachusetts, United States
View all 88 locations
View Trial Details
Completed

Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients

NCT01784068

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Lakes Research Miami Lakes, Florida, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Cancer Center of Kansas Wichita, Kansas, United States
View all 113 locations
View Trial Details

Related conditions